There is a great deal of evidence that altered sphingolipid metabolism is associated with fumonisin-induced
animal diseases including increased apoptotic and oncotic necrosis, and carcinogenesis in
rodent liver and kidney. The biochemical consequences of fumonisin disruption of sphingolipid
metabolism most likely to alter cell regulation are increased free sphingoid bases...